GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Current Ratio

LSB (LakeShore Biopharma Co) Current Ratio : 1.41 (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. LakeShore Biopharma Co's current ratio for the quarter that ended in Sep. 2023 was 1.41.

LakeShore Biopharma Co has a current ratio of 1.41. It generally indicates good short-term financial strength.

The historical rank and industry rank for LakeShore Biopharma Co's Current Ratio or its related term are showing as below:

LSB' s Current Ratio Range Over the Past 10 Years
Min: 1.13   Med: 1.59   Max: 2.12
Current: 1.13

During the past 4 years, LakeShore Biopharma Co's highest Current Ratio was 2.12. The lowest was 1.13. And the median was 1.59.

LSB's Current Ratio is ranked worse than
80.44% of 1503 companies
in the Biotechnology industry
Industry Median: 3.69 vs LSB: 1.13

LakeShore Biopharma Co Current Ratio Historical Data

The historical data trend for LakeShore Biopharma Co's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Current Ratio Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Current Ratio
2.12 1.61 1.57 1.13

LakeShore Biopharma Co Quarterly Data
Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Mar24
Current Ratio Get a 7-Day Free Trial Premium Member Only 1.51 1.57 1.54 1.41 1.13

Competitive Comparison of LakeShore Biopharma Co's Current Ratio

For the Biotechnology subindustry, LakeShore Biopharma Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Current Ratio distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Current Ratio falls into.



LakeShore Biopharma Co Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

LakeShore Biopharma Co's Current Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Current Ratio (A: Mar. 2024 )=Total Current Assets (A: Mar. 2024 )/Total Current Liabilities (A: Mar. 2024 )
=125.414/111.397
=1.13

LakeShore Biopharma Co's Current Ratio for the quarter that ended in Sep. 2023 is calculated as

Current Ratio (Q: Sep. 2023 )=Total Current Assets (Q: Sep. 2023 )/Total Current Liabilities (Q: Sep. 2023 )
=128.065/90.864
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LakeShore Biopharma Co  (NAS:LSB) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


LakeShore Biopharma Co Current Ratio Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.